The prevalence, disease burden and prognosis of COPD in patients with cardiovascular diseases

Trial Identifier:	D2287L00041
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	February 2026
Study Completion Date:	February 2026
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.